including Remicade (infliximab), Enbrel (etanercept), Humira(adalimumab), Cimzia (certolizumab pegol), and Simponi(golimumab)AUDIENCE: Rheumatology, Gastroenterology, OncologyISSUE: FDA notified healthcare professionals that the... (Source: Drugs.com - Pharma News)
Friday 25 November 2011
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment